Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database.
Issa DE, Gelderblom H, Lugtenburg PJ, van Herk-Sukel MP, Houweling LM, De La Orden M, van der Werf-Langenberg ME, Nortier JW, de Jong FA. Issa DE, et al. Among authors: de la orden m, de jong fa. Eur J Cancer Care (Engl). 2015 Mar;24(2):232-41. doi: 10.1111/ecc.12189. Epub 2014 Feb 14. Eur J Cancer Care (Engl). 2015. PMID: 24528512
Management of fatigue in patients with cancer -- a practical overview.
Koornstra RH, Peters M, Donofrio S, van den Borne B, de Jong FA. Koornstra RH, et al. Among authors: de jong fa. Cancer Treat Rev. 2014 Jul;40(6):791-9. doi: 10.1016/j.ctrv.2014.01.004. Epub 2014 Feb 7. Cancer Treat Rev. 2014. PMID: 24576643 Review.
Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens.
Vogel A, Ciardiello F, Hubner RA, Blanc JF, Carrato A, Yang Y, Patel DA, Ektare V, de Jong FA, Gill S. Vogel A, et al. Among authors: de jong fa. Cancer Treat Rev. 2016 Nov;50:142-147. doi: 10.1016/j.ctrv.2016.09.001. Epub 2016 Sep 9. Cancer Treat Rev. 2016. PMID: 27676174 Review.
Role of pharmacogenetics in irinotecan therapy.
de Jong FA, de Jonge MJ, Verweij J, Mathijssen RH. de Jong FA, et al. Among authors: de jonge mj. Cancer Lett. 2006 Mar 8;234(1):90-106. doi: 10.1016/j.canlet.2005.04.040. Epub 2005 Dec 15. Cancer Lett. 2006. PMID: 16343744 Review.
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropenia.
van der Bol JM, de Jong FA, van Schaik RH, Sparreboom A, van Fessem MA, van de Geijn FE, van Daele PL, Verweij J, Sleijfer S, Mathijssen RH. van der Bol JM, et al. Among authors: de jong fa. Oncologist. 2010;15(10):1063-72. doi: 10.1634/theoncologist.2010-0033. Epub 2010 Oct 7. Oncologist. 2010. PMID: 20930093 Free PMC article.
59 results